- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Carfilzomib – November 2018
Carfilzomib: Powder for injection 30 mg, Powder for injection 60 mg; Kyprolis®
Last updated
15 March 2019